Tomosue Kajiwara

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Tomosue Kajiwara is an author at Niigata Cancer Center Hospital specializing in non-small cell lung cancer treatment, cancer pharmacology, and oncology.

Publications per year

2022–2023

Publications

Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study)

Atsushi Nakamura, Ou Yamaguchi, Keita Mori et al. · European Journal of Cancer · 2023 · 20 citations

Medicine, Oncology, Pharmacology +17

Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501)

Satoshi Watanabe, Kazuko Sakai, Naoya Matsumoto et al. · Cancers · 2022 · 12 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

1–2 of 2